Literature DB >> 6945140

Inhibition by clinically used dyes of prostaglandin inactivation in rat and human lung.

Y S Bakhle.   

Abstract

1. The effect of several clinically used dyes on prostaglandin E2 (PGE2) inactivation was studied in rat and human isolated lung. 2. All the dyes, given as infusions through the pulmonary circulation, inhibited the inactivation of PGE2 as measured by bioassay. The action of the dyes was readily reversible on stopping the infusion. 3. The concentration producing 30% inhibition varied from 0.6 microM for indocyanine green to over 100 micro M for methylene blue. 4. Inhibition of PGE2 inactivation was also observed when the dyes were given as bolus injections during PGE2 infusions through the lung. 5. These dyes are therefore not physiologically inert as they had previously been thought to be and their interaction with prostaglandins may affect the variables they are used to measure.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945140      PMCID: PMC2071643          DOI: 10.1111/j.1476-5381.1981.tb09153.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Inhibition of pulmonary prostaglandin metabolism by inhibitors of prostaglandin biotransport (probenecid and bromcresol green).

Authors:  L Z Bito; R A Baroody
Journal:  Prostaglandins       Date:  1975-10

2.  Synthesis and biological properties of 16-alkylprostaglandins.

Authors:  B J Magerlein; D W DuCharme; W E Magee; W L Miller; A Robert; J R Weeks
Journal:  Prostaglandins       Date:  1973-07

3.  Selective passage of prostaglandins across the lung.

Authors:  J C McGiff; N A Terragno; J C Strand; J B Lee; A J Lonigro; K K Ng
Journal:  Nature       Date:  1969-08-16       Impact factor: 49.962

4.  Clinically-used dyes are inhibitors of prostaglandin E2 inactivation in rat isolated lung [proceedings].

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

5.  Prostaglandins: their disappearance from and release into the circulation.

Authors:  S H Ferreira; J R Vane
Journal:  Nature       Date:  1967-12-02       Impact factor: 49.962

6.  Uptake and inactivation of prostaglandin E2 methyl analogues in the rat pulmonary circulation.

Authors:  Y S Bakhle; S Jancar; B J Whittle
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

7.  Prostaglandins A1,A2 and 19-hydroxy A1; their actions on smooth muscle and their inactivation on passage through the pulmonary and hepatic portal vascular beds.

Authors:  E W Horton; R L Jones
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

8.  Reduction of renal function by newer nonsteroidal anti-inflammatory drugs.

Authors:  R P Kimberly; R E Bowden; H R Keiser; P H Plotz
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

9.  Action of prostaglandin dehydrogenase inhibitors on prostaglandin uptake in rat isolated lung.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

10.  The use of the hamster stomach in vitro as an assay preparation for prostaglandins.

Authors:  F B Ubatuba
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

View more
  1 in total

1.  Influence of plasma protein on the inhibitory effects of indocyanine green and bromcresol green on pulmonary prostaglandin E1 extraction.

Authors:  C A Dawson; J H Linehan; D A Rickaby; D L Roerig
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.